These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 31561855)
1. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner. Wei Z; Zhao D; Zhang Y; Chen Y; Zhang S; Li Q; Zeng P; Li X; Zhang W; Duan Y; Han J; Yang X Biochem Biophys Res Commun; 2019 Nov; 519(4):854-860. PubMed ID: 31561855 [TBL] [Abstract][Full Text] [Related]
2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. Chen H; He YW; Liu WQ; Zhang JH World J Gastroenterol; 2008 May; 14(18):2905-11. PubMed ID: 18473419 [TBL] [Abstract][Full Text] [Related]
4. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice. Lv X; Song JG; Li HH; Ao JP; Zhang P; Li YS; Song SL; Wang XR World J Gastroenterol; 2011 Dec; 17(48):5267-73. PubMed ID: 22219595 [TBL] [Abstract][Full Text] [Related]
5. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. Yu Q; Cheng P; Wu J; Guo C J Cell Mol Med; 2021 Feb; 25(3):1645-1660. PubMed ID: 33438347 [TBL] [Abstract][Full Text] [Related]
6. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats. Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc. Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the PPARγ agonist, GW570, in liver fibrosis. Yang L; Stimpson SA; Chen L; Wallace Harrington W; Rockey DC Inflamm Res; 2010 Dec; 59(12):1061-71. PubMed ID: 20585829 [TBL] [Abstract][Full Text] [Related]
9. Lack of Nogo-B expression ameliorates PPARγ deficiency-aggravated liver fibrosis by regulating TLR4-NF-κB-TNF-α axis and macrophage polarization. Zhao D; Xue C; Yang Y; Li J; Wang X; Chen Y; Zhang S; Chen Y; Duan Y; Yang X; Han J Biomed Pharmacother; 2022 Sep; 153():113444. PubMed ID: 36076559 [TBL] [Abstract][Full Text] [Related]
10. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats. Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889 [TBL] [Abstract][Full Text] [Related]
11. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Galli A; Crabb DW; Ceni E; Salzano R; Mello T; Svegliati-Baroni G; Ridolfi F; Trozzi L; Surrenti C; Casini A Gastroenterology; 2002 Jun; 122(7):1924-40. PubMed ID: 12055599 [TBL] [Abstract][Full Text] [Related]
13. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419 [TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-κB Signaling Pathway Inhibition in Bile Duct-Ligated Mice. Weng Z; Chi Y; Xie J; Liu X; Hu J; Yang F; Li L Cell Physiol Biochem; 2018; 49(3):1083-1096. PubMed ID: 30196285 [TBL] [Abstract][Full Text] [Related]
15. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice. Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191 [TBL] [Abstract][Full Text] [Related]
16. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724 [TBL] [Abstract][Full Text] [Related]
17. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model. Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441 [TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats. Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324 [TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effect of astaxanthin against cholestasis liver fibrosis induced by bile duct ligation in adult Wistar rats. Laderian A; Ghasemi M; Mortazavi P; Mousavi Z; Ale-Ebrahim M J Biochem Mol Toxicol; 2024 Aug; 38(8):e23788. PubMed ID: 39087918 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]